Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is scheduled to be issuing its quarterly earnings data on Monday, November 6th. Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) last posted its quarterly earnings data on Friday, August 4th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.02). […]